Who are NoBACZ - company's investors?

NoBACZ - company's investors include Adjuvo, Cambridge Angels group, EMV Capital, Martlet Capital, The FSE Group, The Yield Lab Europe, ACF Investors, The Yield Lab.

NoBACZ - company

28 employees on LinkedIn · 8 known investors

Find your way into NoBACZ - company

Paths you didn't know you had: your email and LinkedIn already hold routes to the NoBACZ - company team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials. Its biodegradable formulas target animal health applications such as protecting hooves, horn buds and udders in farm environments, with active research collaborations with universities.

AgTech Biotech Healthtech New Materials

Founders & leadership

Jonathan Powell Chief Executive OfficerJonathan Powell is CEO of NoBACZ Healthcare, a University of Cambridge spin-out developing antibiotic-free wound care products for veterinary applications. He holds a Research Professor position at Cambridge and has over 30 years of experience in biomedical research, including prior roles at the MRC and King's College London, with expertise in biomineral science and nanomedicine.

Investors · 8

Adjuvolisted by AdjuvoLondon

How we know: Adjuvo's portfolio page · Not right? Tell us

Cambridge Angels grouplisted by Cambridge Angels groupCambridge · $195K – $1.9M

How we know: Cambridge Angels group's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

EMV Capitallisted by EMV CapitalLondon

How we know: EMV Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Martlet Capitallisted by Martlet CapitalCambridge · $317.5K

The FSE Grouplisted by The FSE GroupFleet · $25K – $5M

How we know: The FSE Group's portfolio page · Not right? Tell us

The Yield Lab Europelisted by The Yield Lab EuropeDublin · $108K – $2.2M

How we know: The Yield Lab Europe's portfolio page · the VCSheet dataset · Not right? Tell us

ACF InvestorsreportedSheffield · $125K – $1.3M

How we know: a partner's Signal profile · Not right? Tell us

The Yield LabreportedSingapore

How we know: the VCSheet dataset · Not right? Tell us

Related companies · 1

NflThe National Football League (NFL) is a professional sports organization that operates a league of American football teams and produces content related to professional football, including news, fantasy sports, and merchandise.

Companies working in the same space as NoBACZ - company.

Frequently asked questions

What does NoBACZ - company do?: NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials. Its biodegradable formulas target animal health applications such as protecting hooves, horn buds and udders in farm environments, with active research collaborations with universities.
Who are NoBACZ - company's investors?: NoBACZ - company's investors include Adjuvo, Cambridge Angels group, EMV Capital, Martlet Capital, The FSE Group, The Yield Lab Europe, ACF Investors, The Yield Lab.